Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers.

Correction: Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers. PLoS One (2015) 0.75

Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis. PLoS One (2016) 0.75

Recent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders. Genomics Proteomics Bioinformatics (2017) 0.75

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83

Identification of host proteins required for HIV infection through a functional genomic screen. Science (2008) 12.44

Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell (2008) 8.41

Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe (2008) 6.24

Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature (2010) 4.23

Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet (1996) 3.65

Redox regulation of cellular activation. Annu Rev Immunol (1997) 3.17

HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS (2008) 2.67

Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell (2007) 2.22

Risk factors for postnatal mother-child transmission of HIV-1. AIDS (2000) 2.08

The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity. Nature (2006) 2.02

Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. J Immunol (2005) 1.82

Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One (2010) 1.73

Antimicrobial components of vaginal fluid. Am J Obstet Gynecol (2002) 1.67

Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS (2000) 1.66

Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples. AIDS (2012) 1.64

Psoriasin: a novel chemotactic protein. J Invest Dermatol (1996) 1.59

Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. Oral Dis (1997) 1.58

A super-family of medium-chain dehydrogenases/reductases (MDR). Sub-lines including zeta-crystallin, alcohol and polyol dehydrogenases, quinone oxidoreductase enoyl reductases, VAT-1 and other proteins. Eur J Biochem (1994) 1.56

Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains. J Biol Chem (1996) 1.41

Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol (2007) 1.41

The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection. J Exp Med (2007) 1.37

Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers. Clin Diagn Lab Immunol (2000) 1.26

Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci U S A (2001) 1.24

Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion. J Acquir Immune Defic Syndr (2014) 1.23

Proteomic analysis of human cervico-vaginal fluid. J Proteome Res (2007) 1.23

Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS (2009) 1.21

Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers. J Proteome Res (2008) 1.18

Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cell Microbiol (2009) 1.16

The identification of a novel human homologue of the SH3 binding glutamic acid-rich (SH3BGR) gene establishes a new family of highly conserved small proteins related to Thioredoxin Superfamily. Gene (2002) 1.14

Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female sex workers. J Proteome Res (2011) 1.13

Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J Infect Dis (2014) 1.10

HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family. J Biol Chem (2002) 1.09

Antimicrobial peptides in the pathogenesis of psoriasis. J Dermatol (2012) 1.06

Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus. Virol J (2010) 1.05

Thioredoxin as a potent costimulus of cytokine expression. J Immunol (1996) 1.03

A systems biology examination of the human female genital tract shows compartmentalization of immune factor expression. J Virol (2013) 0.97

Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1. Biochem J (2006) 0.97

Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens. Am J Reprod Immunol (2014) 0.96

HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships. PLoS One (2012) 0.94

Acting locally: innate mucosal immunity in resistance to HIV-1 infection in Kenyan commercial sex workers. Mucosal Immunol (2013) 0.93

HIV acquisition is associated with increased antimicrobial peptides and reduced HIV neutralizing IgA in the foreskin prepuce of uncircumcised men. PLoS Pathog (2014) 0.92

Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs (2013) 0.92

Human cervicovaginal lavage fluid contains an inhibitor of HIV binding to dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Infect Dis (2005) 0.91

Innate immunity in the vagina (part I): estradiol inhibits HBD2 and elafin secretion by human vaginal epithelial cells. Am J Reprod Immunol (2013) 0.90

Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection. Virology (2003) 0.90

Mucosal serpin A1 and A3 levels in HIV highly exposed sero-negative women are affected by the menstrual cycle and hormonal contraceptives but are independent of epidemiological confounders. Am J Reprod Immunol (2012) 0.89

The effects of reproductive hormones on the physical properties of cervicovaginal fluid. Am J Obstet Gynecol (2014) 0.88

The tumor marker human placental protein 11 is an endoribonuclease. J Biol Chem (2008) 0.87

Status of antioxidants and other biochemical abnormalities in children with dengue fever. J Trop Pediatr (1999) 0.86

S100A11, a dual growth regulator of epidermal keratinocytes. Amino Acids (2010) 0.84

The antimicrobial protein S100A7/psoriasin enhances the expression of keratinocyte differentiation markers and strengthens the skin's tight junction barrier. Br J Dermatol (2014) 0.83

Innate molecular and anatomic mucosal barriers against HIV infection in the genital tract of HIV‐exposed seronegative individuals. J Infect Dis (2010) 0.83

Neutrophil elastase induces MUC5AC secretion via protease-activated receptor 2. Mol Cell Biochem (2013) 0.83

Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1. J Exp Med (1994) 0.81

Myristoylated Alanine Rich C Kinase Substrate (MARCKS) is essential to β2-integrin dependent responses of equine neutrophils. Vet Immunol Immunopathol (2014) 0.81

Human VAT-1: a calcium-regulated activation marker of human epithelial cells. Arch Dermatol Res (2003) 0.79

Peptide-mediated interference with baculovirus transduction. J Biotechnol (2008) 0.78

The structure of S100A11 fragment explains a local structural change induced by phosphorylation. J Pept Sci (2008) 0.77

Human rElafin Inhibits HIV-1 Replication in Its Natural Target Cells. Biores Open Access (2013) 0.77

Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity are Consistent with Inter-Subtype Differences in HIV-1 Disease Progression. J Virol (2017) 0.75